Ali, M. A., Bastian, S., Ismail, R., Choon, T. S., Ali, S., Aubry, A., Pandian, S., Saraswat, P., Singh, A. and Gaur, R. (2011). Discovery of novel methanone derivatives acting as antimycobacterial agents. Journal of Enzyme Inhibition and Medicinal Chemistry 26, 890–894, http://doi.org/10.3109/14756366.2011.559945.
Antoun, F. and Veziris, N. (2011). Gestion des tuberculoses multirésistantes. Revue des Maladies Respiratoires 28, 956–957, http://doi.org/10.1016/j.rmr.2011.06.010.
Bastian, S., Veziris, N., Roux, A.-L., Brossier, F., Gaillard, J.-L., Jarlier, V. and Cambau, E. (2011). Assessment of Clarithromycin Susceptibility in Strains Belonging to the Mycobacterium abscessus Group by erm(41) and rrl Sequencing. Antimicrob Agents Chemother 55, 775–781, http://doi.org/10.1128/AAC.00861-10.
Bouakaze, C., Keyser, C., Gonzalez, A., Sougakoff, W., Veziris, N., Dabernat, H., Jaulhac, B. and Ludes, B. (2011). Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry-Based Single Nucleotide Polymorphism Genotyping Assay Using iPLEX Gold Technology for Identification of Mycobacterium tuberculosis Complex Species and Lineages. J Clin Microbiol 49, 3292–3299, http://doi.org/10.1128/JCM.00744-11.
Brossier, F. (2011). Mécanismes d’action et de résistance de l’isoniazide, un antituberculeux de première ligne. Journal des Anti-Infectieux 13, 217–227, http://doi.org/10.1016/j.antinf.2011.10.003.
Brossier, F., Veziris, N., Truffot-Pernot, C., Jarlier, V. and Sougakoff, W. (2011). Molecular Investigation of Resistance to the Antituberculous Drug Ethionamide in Multidrug-Resistant Clinical Isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, 355–360, http://doi.org/10.1128/AAC.01030-10.
Cambau, E. and Rüsch-Gerdes, S. (2011). First- and second-line drug susceptibility testing for Mycobacterium tuberculosis complex, ECDC, Stockholm, URL: https://op.europa.eu/en/publication-detail/-/publication/9803f7a5-6188-48f2-84cd-d83f0b95c0c1/language-en.
Couderc, C., Carbonne, A., Thiolet, J. M., Brossier, F., Savey, A., Bernet, C., Ortmans, C., Lecadet-Morin, C., Coudière, I., Aggoune, M., Astagneau, P., Coignard, B. and Cambau, E. (2011). Infections à mycobactéries atypiques liées à des soins esthétiques en France, 2001–2010. Médecine et Maladies Infectieuses 41, 379–383, http://doi.org/10.1016/j.medmal.2011.02.007.
Cribier, B., Aubry, A., Caumes, E., Cambau, E., Jarlier, V. and Chosidow, O. (2011). [Histopathological study of Mycobacterium marinum infection]. Ann Dermatol Venereol 138, 17–22, http://doi.org/10.1016/j.annder.2010.10.025.
Fauville-Dufaux, M., Jarlier, V., van Soolingen, D. and Hoffner, S. (2011). Biosafety in the clinical laboratory diagnosis of tuberculosis. In: Mastering the basics of TB control - Development of a handbook on TB diagnostic methods, ECDC, Stockholm, pp. 11–18, URL: doi 10.2900/39099.
Lerat, I., Truffot, C. and Veziris, N. (2011). Infections à Mycobacterium abscessus : épidémiologie, aspects cliniques et traitement. Journal des Anti-infectieux 13, 49–55.
Macheras, E., Roux, A.-L., Bastian, S., Leão, S. C., Palaci, M., Sivadon-Tardy, V., Gutierrez, C., Richter, E., Rüsch-Gerdes, S., Pfyffer, G., Bodmer, T., Cambau, E., Gaillard, J.-L. and Heym, B. (2011). Multilocus Sequence Analysis and rpoB Sequencing of Mycobacterium abscessus (Sensu Lato) Strains. J Clin Microbiol 49, 491–499, http://doi.org/10.1128/JCM.01274-10.
Pantel, A., Petrella, S., Matrat, S., Brossier, F., Bastian, S., Reitter, D., Jarlier, V., Mayer, C. and Aubry, A. (2011). DNA Gyrase Inhibition Assays Are Necessary To Demonstrate Fluoroquinolone Resistance Secondary to gyrB Mutations in Mycobacterium tuberculosis. Antimicrob Agents Chemother 55, 4524–4529, http://doi.org/10.1128/AAC.00707-11.
Petrella, S., Gelus-Ziental, N., Maudry, A., Laurans, C., Boudjelloul, R. and Sougakoff, W. (2011). Crystal Structure of the Pyrazinamidase of Mycobacterium tuberculosis : Insights into Natural and Acquired Resistance to Pyrazinamide. PLOS ONE 6, e15785, http://doi.org/10.1371/journal.pone.0015785.
Prevotat, A., Bonne, S., Veziris, N., Senneville, E., Yazdanpanah, Y. and Legout, L. (2011). [Mycobacterium abscessus pulmonary infection treated with tigecyclin-amikacin and cefoxitin in a diabetic patient]. Med Mal Infect 41, 446–448, http://doi.org/10.1016/j.medmal.2011.02.011.
Radomski, N., Betelli, L., Moilleron, R., Haenn, S., Moulin, L., Cambau, E., Rocher, V., Gonçalves, A. and Lucas, F. S. (2011). Mycobacterium Behavior in Wastewater Treatment Plant, A Bacterial Model Distinct From Escherichia coli and Enterococci. Environ Sci Technol 45, 5380–5386, http://doi.org/10.1021/es104084c.
Schneider, P., Monsel, G., Veziris, N., Roujeau, J.-C., Bricaire, F. and Caumes, E. (2011). Successful treatment of nodular lymphangitis due to in two immunosuppressed patients. Dermatology Online Journal 17, URL: http://escholarship.org/uc/item/8f55s44k [Accessed September 2013].
Sougakoff, W. (2011). Molecular epidemiology of multidrug-resistant strains of Mycobacterium tuberculosis. Clinical Microbiology and Infection 17, 800–805, http://doi.org/10.1111/j.1469-0691.2011.03577.x.
Tochon, M., Bosdure, E., Salles, M., Beloncle, C., Chadelat, K., Dagorne, M., Gaudelus, J., Losi, S., Renoux, M. C., Veziris, N. and Dubus, J. C. (2011). Management of young children in contact with an adult with drug-resistant tuberculosis, France, 2004-2008. Int J Tuberc Lung Dis 15, 326–330.
Truffot-Pernot, C. and Veziris, N. (2011). Les tests bactériologiques de la tuberculose maladie : standards et perspectives. Revue des Maladies Respiratoires 28, 1034–1047, http://doi.org/10.1016/j.rmr.2011.07.002.
van Soolingen, D., Jarlier, V. and Drobniewski, F. (2011). Information for physicians: the laboratory diagnosis of tuberculosis – first steps. In: Mastering the basics of TB control - Development of a handbook on TB diagnostic methods, ECDC, Stockholm, pp. 96–99, URL: doi 10.2900/39099.
Veziris, N., Truffot, C., Mainardi, J.-L. and Jarlier, V. (2011). Activity of carbapenems combined with clavulanate in murine tuberculosis. Antimicrob Agents Chemother, http://doi.org/10.1128/AAC.01824-10.
Veziris, N., Ibrahim, M., Lounis, N., Andries, K. and Jarlier, V. (2011). Sterilizing Activity of Second-Line Regimens Containing TMC207 in a Murine Model of Tuberculosis. PLoS ONE 6, e17556, http://doi.org/10.1371/journal.pone.0017556.